RENALGUARD SOLUTIONS
Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard's effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA.
RENALGUARD SOLUTIONS
Industry:
Health Care Manufacturing Medical Medical Device
Founded:
2013-04-01
Address:
Milford, Massachusetts, United States
Country:
United States
Website Url:
http://www.renalguard.com
Total Employee:
11+
Status:
Active
Contact:
(508)541-8800
Email Addresses:
[email protected]
Total Funding:
21.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
SyMap Medical
SyMap Medical is an innovative medical device company.
Current Advisors List
Current Employees Featured
Investors List
Abiomed
Abiomed investment in Series B - RenalGuard Solutions
Official Site Inspections
http://www.renalguard.com Semrush global rank: 8.59 M Semrush visits lastest month: 284
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "RenalGuard Solutions"
RenalGuard - Main Home - CardioRenal Systems
The RenalGuard / RenalPro system and treatment have not been approved or cleared by the U.S. Food and Drug Administration (FDA). This device is currently available only for investigational use and is intended solely for use in clinical …See details»
RenalGuard Solutions - Crunchbase Company Profile
RenalGuard Solutions, Inc., is a medical device company.Headquarters Regions East Coast, New England, Northeastern US Founded Date Apr 2013 …See details»
RenalGuard Solutions, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for RenalGuard Solutions, Inc. of Milford, MA. Get the latest business insights from Dun & Bradstreet.See details»
RenalGuard Solutions, Inc. - Radcliffe Vascular
RenalGuard Solutions, Inc., is a medical device company focused on innovative technologies for the cardiac and vascular markets. Our lead product, RenalGuard®, is designed to rapidly …See details»
Medizintechnikunternehmen RenalGuard | RenalGuard
RenalGuard ® Solutions is a medical device company specializing in innovative solutions in the field of cardiovascular disease. The lead product RenalGuard ®was developed to flush the contrast medium, which is used in many …See details»
RenalGuard Solutions Company Profile | Management and
RenalGuard Solutions Profile and History Milford, MA-based RenalGuard Solutions, Inc. is a medical device company focused on innovative technologies for the cardiac and vascular …See details»
RenalGuard Company Profile 2024: Valuation, Funding & Investors …
Information on valuation, funding, cap tables, investors, and executives for RenalGuard. Use the PitchBook Platform to explore the full profile.See details»
RenalGuard Solutions - 2025 Company Profile - Tracxn
May 30, 2025 RenalGuard Solutions, formerly known as PLC Medical, is a medical device company focused on technologies for the cardiac and vascular markets. Their lead product, …See details»
RenalGuard Solutions - Products, Competitors, Financials, …
RenalGuard Solutions is a medical technology company focused on preventing acute kidney injury (AKI) within the cardiac surgery domain. The company's main product, RenalPro …See details»
RENALGUARD SOLUTIONS UK LIMITED - Companies House
RENALGUARD SOLUTIONS UK LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»
Study Evaluating the Use of RenalGuard to Protect …
Jul 27, 2022 The study was sponsored by RenalGuard Solutions Inc (Milford, Massachusetts, USA) and coordinated by an independent contract research organization (Cardiovascular European Research Center, Massy, France), …See details»
RenalGuard reduces acute kidney injury
RenalGuard Therapy ® measures a patient’s urine output and then infuses a volume of saline to maintain the desired fluid balance. It is a closed loop system designed to minimise the risk of …See details»
RenalGuard Solutions - Contacts, Employees, Board Members, …
RenalGuard Solutions, Inc., is a medical device company.RenalGuard Solutions has 3 current employee profiles, including Board Member Ethan Benovitz. RenalGuard Solutions has 1 …See details»
Cardio - RenalGuard - EPS Vascular
RenalGuard by RenalGuard Solutions, Inc. RenalGuard Therapy® A Therapeutic Approach to Reducing Contrast-Induced Nephropathy RenalGuard Therapy® is designed to reduce the …See details»
CardioRenal Systems’ RenalGuard receives FDA designation
Jan 23, 2023 The RenalGuard Therapy is indicated for preventing acute kidney injury in people who are at risk of developing Cardiac Surgery Associated AKI. Credit: RenalGuard Solutions / …See details»
Study Evaluating the Use of RenalGuard to Protect ... - ScienceDirect
Aug 22, 2022 The study was sponsored by RenalGuard Solutions Inc (Milford, Massachusetts, USA) and coordinated by an independent contract research organization (Cardiovascular …See details»
RenalPro Therapy - CardioRenal Systems
The RenalPro™ System stands out for its simple, elegant technology: ideal for kidney preservation and AKI prevention. Widely endorsed by surgeons and anesthesiologists, the …See details»
by RenalGuard Solutions, Inc.
RenalGuard Therapy entails the use of a physician-prescribed loop diuretic which may induce the required high urine output. RenalGuard System is designed to measure urine output and …See details»
RenalGuard Therapy® Receives FDA Breakthrough Device …
MILFORD, Mass., Jan. 20, 2023 /PRNewswire/ — CardioRenal Systems, Inc. announced today that the FDA granted Breakthrough Device Designation for its RenalGuard Therapy ® device …See details»
CardioRenal secures FDA Breakthrough Designation for RenalGuard
Jan 23, 2023 RenalGuard Therapy better protects at-risk patients undergoing cardiac surgery. (Credit: PRNewswire / RenalGuard Solutions) CardioRenal Systems has received the US …See details»